“Data from our phase 3 study compared the safety and efficacy of omidubicel to standard cord blood. We are delighted to have the opportu (. )

A growing body of clinical evidence suggests meaningful benefit and sustained improvements in physical, functional and overall well-being compared to umbilical cord transplantation.